1. Home
  2. HOWL vs IVCA Comparison

HOWL vs IVCA Comparison

Compare HOWL & IVCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • IVCA
  • Stock Information
  • Founded
  • HOWL 2017
  • IVCA 2021
  • Country
  • HOWL United States
  • IVCA Cayman Islands
  • Employees
  • HOWL N/A
  • IVCA N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • IVCA Blank Checks
  • Sector
  • HOWL Health Care
  • IVCA Finance
  • Exchange
  • HOWL Nasdaq
  • IVCA Nasdaq
  • Market Cap
  • HOWL 87.4M
  • IVCA 92.4M
  • IPO Year
  • HOWL 2021
  • IVCA 2022
  • Fundamental
  • Price
  • HOWL $1.79
  • IVCA $11.68
  • Analyst Decision
  • HOWL Strong Buy
  • IVCA
  • Analyst Count
  • HOWL 2
  • IVCA 0
  • Target Price
  • HOWL $13.50
  • IVCA N/A
  • AVG Volume (30 Days)
  • HOWL 656.6K
  • IVCA 350.0
  • Earning Date
  • HOWL 11-07-2024
  • IVCA 01-01-0001
  • Dividend Yield
  • HOWL N/A
  • IVCA N/A
  • EPS Growth
  • HOWL N/A
  • IVCA N/A
  • EPS
  • HOWL N/A
  • IVCA N/A
  • Revenue
  • HOWL $3,386,000.00
  • IVCA N/A
  • Revenue This Year
  • HOWL N/A
  • IVCA N/A
  • Revenue Next Year
  • HOWL $191.98
  • IVCA N/A
  • P/E Ratio
  • HOWL N/A
  • IVCA $48.77
  • Revenue Growth
  • HOWL N/A
  • IVCA N/A
  • 52 Week Low
  • HOWL $1.58
  • IVCA $10.88
  • 52 Week High
  • HOWL $8.19
  • IVCA $12.37
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 32.55
  • IVCA 80.56
  • Support Level
  • HOWL $1.58
  • IVCA $11.44
  • Resistance Level
  • HOWL $2.24
  • IVCA $11.50
  • Average True Range (ATR)
  • HOWL 0.16
  • IVCA 0.00
  • MACD
  • HOWL -0.09
  • IVCA -0.00
  • Stochastic Oscillator
  • HOWL 7.01
  • IVCA 100.00

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About IVCA Investcorp India Acquisition Corp.

Investcorp India Acquisition Corp is a newly organized blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: